Systematic review of artificial intelligence for personalized oral anticoagulation management in cardiovascular care

Artificial intelligence and machine learning are increasingly used to personalize oral anticoagulation. We systematically reviewed patient-level studies in adults actively receiving warfarin, vitamin K antagonists, or direct oral anticoagulants. PubMed, Europe PMC, and Scopus were searched from inception to 15 August 2026. Of 984 records, 54 studies met eligibility criteria after duplicate removal, title and abstract screening, and full-text assessment. Applications included dose optimization and anticoagulation control, prediction of bleeding and thromboembolic outcomes, and individualized treatment selection. Warfarin dominated dose-optimization research, whereas direct oral anticoagulants were more prominent in risk and comparative-treatment modelling. Across the evidence base, limited external validation, inconsistent calibration, and sparse prospective evaluation restricted clinical translation. AI-enabled anticoagulation is progressing from static prediction toward longitudinal and treatment-specific decision support, but robust multicentre validation remains essential.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11296432/v1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Systematic review of artificial intelligence for personalized oral anticoagulation management in cardiovascular care

Rosnani Hashim, Nurul Adilla Hayat Jamaluddin, Farizan binti Abdul Ghaffar, Ahmed Alaqab et al.
6 links
Research Square
Atrial Fibrillation Management and Outcomes
preprint

Systematic review of artificial intelligence for personalized oral anticoagulation management in cardiovascular care

Rosnani Hashim, Nurul Adilla Hayat Jamaluddin, Farizan binti Abdul Ghaffar, Ahmed Alaqab, Maali Mujahid Mustafa¹
preprint en

Abstract

Artificial intelligence and machine learning are increasingly used to personalize oral anticoagulation. We systematically reviewed patient-level studies in adults actively receiving warfarin, vitamin K antagonists, or direct oral anticoagulants. PubMed, Europe PMC, and Scopus were searched from inception to 15 August 2026. Of 984 records, 54 studies met eligibility criteria after duplicate removal, title and abstract screening, and full-text assessment. Applications included dose optimization and anticoagulation control, prediction of bleeding and thromboembolic outcomes, and individualized treatment selection. Warfarin dominated dose-optimization research, whereas direct oral anticoagulants were more prominent in risk and comparative-treatment modelling. Across the evidence base, limited external validation, inconsistent calibration, and sparse prospective evaluation restricted clinical translation. AI-enabled anticoagulation is progressing from static prediction toward longitudinal and treatment-specific decision support, but robust multicentre validation remains essential.

Research Square
Hospital Kuala Lumpur (MY), University of Cyberjaya (MY)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon